Regulation of dynamin 2 and G protein-coupled receptor kinase 2 in rat nucleus accumbens during acute and repeated cocaine administration

Synapse

Volumn 63, Issue 10, 2009, Pages 863-870

  Schroeder, Joseph A ^a   McCafferty, Mary R ^a   Unterwald, Ellen M ^a,b  

^a TEMPLE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b ROCKEFELLER UNIVERSITY   (United States)

Author keywords

Binge cocaine; Dynamin 2; GRK2; Receptor trafficking; Striatum

Indexed keywords

8 CHLORO 2,3,4,5 TETRAHYDRO 3 METHYL 5 PHENYL 1H 3 BENZAZEPIN 7 OL HYDROGEN MALEATE; COCAINE; DYNAMIN II; ETICLOPRIDE; G PROTEIN COUPLED RECEPTOR KINASE 2;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN REGION; CAUDATE NUCLEUS; CONTROLLED STUDY; FRONTAL CORTEX; IMMUNOREACTIVITY; MALE; NONHUMAN; NUCLEUS ACCUMBENS; PRIORITY JOURNAL; PROTEIN TRANSPORT; PUTAMEN; RAT; SUBSTANTIA NIGRA; UPREGULATION; WESTERN BLOTTING;

ANALYSIS OF VARIANCE; ANIMALS; BENZAZEPINES; COCAINE; DOPAMINE ANTAGONISTS; DOPAMINE UPTAKE INHIBITORS; DRUG ADMINISTRATION SCHEDULE; DYNAMIN II; G-PROTEIN-COUPLED RECEPTOR KINASE 2; MALE; NUCLEUS ACCUMBENS; RATS; RATS, INBRED F344; SALICYLAMIDES; TIME FACTORS; UP-REGULATION;

EID: 70349114286     PISSN: 08874476     EISSN: 10982396     Source Type: Journal    
DOI: 10.1002/syn.20669     Document Type: Article

References (38)

1. Cass WA, Gerhardt GA, Gillespie K, Curella P, Mayfield RD, Zahniser NR. 1993. Reduced clearance of exogenous dopamine in rat nucleus accumbens, but not in dorsal striatum, following cocaine challenge in rats withdrawn from repeated cocaine administration. J Neurochem 61:273-283. (Pubitemid 23175911)
2. Chefer VI, Shippenberg TS. 2002. Changes in basal and cocaine-evoked extracellular dopamine uptake and release in the rat nucleus accumbens during early abstinence from cocaine: Quantitative determination under transient conditions. Neuroscience 112:907-919.
3. Chen JF, Aloyo VJ, Weiss B. 1993. Continuous treatment with the D2 dopamine receptor agonist quinpirole decreases D2 dopamine receptors. D2 dopamine receptor messenger RNA and proenkephalin messenger RNA, and increases mu opioid receptors in mouse striatum. Neuroscience 654:669-680.
4. Cook TA, Urrutia R, McNiven MA. 1994. Identification of dynamin 2, an isoform ubiquitously expressed in rat tissues. Proc Natl Acad Sci USA 91:644-648. (Pubitemid 24041458)
5. Daniels GM, Amara SG. 1999. Regulated trafficking of the human dopamine transporter. Clathrin-mediated internalization and lysosomal degradation in response to phorbol esters. J Biol Chem 274:35794-35801.
6. Danino D, Hinshaw JE. 2001. Dynamin family of mechanoenzymes. Curr Opin Cell Biol 13:454-460.
7. Erdtmann-Vourliotis M, Mayer P, Ammon S, Riechert U, Höllt V. 2001. Distribution of G-protein-coupled receptor kinase (GRK) isoforms 2, 3, 5 and 6 mRNA in the rat brain. Mol Brain Res 95:129-137.
8. Ferguson SS, Barak LS, Zhang J, Caron MG. 1996. G-protein-coupled receptor regulation: Role of G protein coupled receptor kinases and arrestins. Can J Physiol Pharmacol 74:1095-1110. (Pubitemid 27047505)
9. Goeders NE, Kuhar MJ. 1987. Chronic cocaine administration induces opposite changes in dopamine receptors in the striatum and nucleus accumbens. Alcohol Drug Res 7:207-216.
10. Hammer RP. 1989. Cocaine alters opiate receptor binding in critical brain reward regions. Synapse 3:55-60.
11. Ito K, Haga T, Lameh J, Sadee W. 1999. Sequestration of dopamine D2 receptors depends on coexpression of G-protein-coupled receptor kinases 2 or 5. Eur J Biochem 260:112-119. (Pubitemid 29095701)
12. Iwata K, Ito K, Fukuzaki A, Inaki K, Haga T. 1999. Dynamin and rab5 regulate GRK2-dependent internalization of dopamine D2 receptors. Eur J Biochem 263:596-602. (Pubitemid 29337054)
13. Izenwasser S. 2004. The role of the dopamine transporter in cocaine abuse. Neurotox Res 6:379-383.
14. Kabbani N, Jeromin A, Levenson R. 2004. Dynamin-2 associates with the dopamine receptor signalplex and regulates internalization of activated D2 receptors. Cell Signal 16:497-503. (Pubitemid 38058632)
15. Keith DE, Anton B, Murray RS, Zaki PA, Chu PC, Lissin DV, Monteillet-Agius G, Stewart PL, Evans CJ, von Zastrow M. 1998. mu-Opioid receptor internalization: Opiate drugs have differential effects on a conserved endocytic mechanism in vitro and in the mammalian brain. Mol Pharmacol 53:377-384. (Pubitemid 28162857)
16. Kleven MS, Perry DB, Woolverton WL, Seiden LS. 1990. Effects of repeated injection of cocaine on D1 and D2 dopamine receptors in rat brain. Brain Res 532:265-270.
17. Lamey M, Thompson M, Varghese G, Chi H, Sawzdargo M, George SR, O'Dowd BF. 2002. Distinct residues in the carboxyl tail mediate agonist-induced desensitization and internalization of the human dopamine D1 receptor. J Biol Chem 277:9415-9421. (Pubitemid 34953027)
18. Lecca D, Cacciapaglia F, Valentini V, Acquas E, Di Chiara G. 2007. Differential neurochemical and behavioral adaptation to cocaine after response contingent and noncontingent exposure in the rat. Psychopharmacology 191:653-667. (Pubitemid 46355877)
19. Letchworth SR, Daunais JB, Hedgecock AA, Porrino LJ. 1997. Effects of chronic cocaine administration on dopamine transporter mRNA and protein in the rat. Brain Res 750:214-222.
20. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. 1951. Protein measurement with the Folin phenol reagent. J Biol Chem 193:265-275.
21. Miguens M, Crespo JA, Del Olmo N, Higuera-Matas A, Montoya GL, Garcia-Lecumberri C, Ambrosio E. 2008. Differential cocaine-induced modulation of glutamate and dopamine transporters after contingent and con-contingent administration. Neuropharmacology 55:771-779.
22. Patel M, Gomes B, Patel C, Yoburn BC. 2002. Antagonist-induced mu-opioid receptor up-regulation decreases G-protein receptor kinase-2 and dynamin-2 abundance in mouse spinal cord. Eur J Pharmacol 446:37-42. (Pubitemid 34722555)
23. Patel CN, Rajashekara V, Patel K, Purohit V, Yoburn BC. 2003. Chronic opioid antagonist treatment selectively regulates trafficking and signaling proteins in mouse spinal cord. Synapse 50:67-76. (Pubitemid 37034114)
24. Peris J, Boyson SJ, Cass WA, Curella P, Dwoskin LP, Larson G, Lin LH, Yasuda RP, Zahniser NR. 1990. Persistence of neurochemical changes in dopamine systems after repeated cocaine administration. J Pharmacol Exp Ther 253:38-44. (Pubitemid 20141475)
25. Pilotte NS, Sharpe LG, Kuhar MJ. 1994. Withdrawal of repeated intravenous infusions of cocaine persistently reduces binding to dopamine transporters in the nucleus accumbens of Lewis rats. J Pharmacol Exp Ther 269:963-969.
26. Samuvel DJ, Jayanthi LD, Manohar S, Kaliyaperumal K, See RE, Ramamoorthy S. 2008. Dysregulation of dopamine transporter trafficking and function after abstinence from cocaine self-administration in rats: Evidence for differential regulation in caudate putamen and nucleus accumbens. J Pharmacol Exp Ther 325:293-301.
27. Saunders C, Ferrer JV, Shi L, Chen J, Merrill G, Lamb ME, Leeb-Lundberg LM, Carvelli L, Javitch JA, Galli A. 2000. Amphetamine-induced loss of human dopamine transporter activity: An internalization-dependent and cocaine-sensitive mechanism. Proc Natl Acad Sci USA 97:6850-6855. (Pubitemid 30412803)
28. Tiberi M, Nash SR, Bertrand L, Lefkowitz RJ, Caron MG. 1996. Differential regulation of dopamine D1A receptor responsiveness by various G protein-coupled receptor kinases. J Biol Chem 271:3771-3778. (Pubitemid 26065697)
29. Unterwald EM. 2001. Regulation of opioid receptors by cocaine. In: Quinones-Jenab V, editor. The biological basis of cocaine addiction, Vol.937. New York: Annals of New York Academy of Science. p 74-92.
30. Unterwald EM, Horne-King J, Kreek MJ. 1992. Chronic cocaine alters brain mu opioid receptors. Brain Res 584:314-318.
31. Unterwald EM, Ho A, Rubenfeld JM, Kreek MJ. 1994. Time course of the development of sensitization and dopamine receptor upregulation during binge cocaine administration. J Pharmacol Exp Ther 270:1387-1397. (Pubitemid 24315265)
32. Unterwald EM, Anton B, To T, Lam H, Evans CJ. 1998. Quantitative immunolocalization of mu opioid receptors: Regulation by naltrexone. Neuroscience 85:897-905. (Pubitemid 28223650)
33. Unterwald EM, Kreek MJ, Cuntapay M. 2001. The frequency of cocaine administration impacts cocaine-induced receptor alterations. Brain Res 900:103-109. (Pubitemid 32452269)
34. Vickery RG, von Zastrow M. 1999. Distinct dynamin-dependent and -independent mechanisms target structurally homologous dopamine receptors to different endocytic membranes. J Cell Biol 144:31-43.
35. Yoburn BC, Goodman RR, Cohen AH, Pasternak GW, Inturrisi CE. 1985. Increased analgesic potency of morphine and increased brain opioid binding sites in the rat following chronic naltrexone treatment. Life Sci 36:2325-2332.
36. Zahniser NR, Doolen S. 2001. Chronic and acute regulation of Na/Cl-dependent neurotransmitter transporters: Drugs, substrates, presynaptic receptors, and signaling systems. Pharmacol Ther 92:21-55. (Pubitemid 34032021)
37. Zhang J, Vinuela A, Neely MH, Hallett PJ, Grant SG, Miller GM, Isacson O, Caron MG, Yao WD. 2007. Inhibition of the dopamine D1 receptor signaling by PSD-95. J Biol Chem 282:15778-15789. (Pubitemid 47093305)
38. Zukin RS, Sugarman JR, Fitz-Syage ML, Gardner EL, Zukin SR, Gintzler AR. 1982. Naltrexone-induced opiate receptor supersensitivity. Brain Res 245:285-292.